Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects
Clinical trial NCT05238714 · COMPLETED
Trial details
- NCT number
- NCT05238714
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2020-06-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.